According to previous reports, IL-1 inhibition did not resolve neutropenia in PAMI syndrome (1, 25), whereas it was effectively used for pyrin inflammasome–associated inflammation control in other autoinflammatory disorders (27, 28). This evidence concerns the gene IL1B and Decreased total neutrophil count.